Baird William D Iii - Net Worth and Insider Trading

Baird William D Iii Net Worth

The estimated net worth of Baird William D Iii is at least $2 Million dollars as of 2024-05-10. Baird William D Iii is the COO of 2seventy bio Inc and owns about 252,335 shares of 2seventy bio Inc (TSVT) stock worth over $1 Million. Baird William D Iii is the CFO of Amicus Therapeutics Inc and owns about 117,622 shares of Amicus Therapeutics Inc (FOLD) stock worth over $1 Million. Baird William D Iii is also the CFO of bluebird bio Inc and owns about 35,529 shares of bluebird bio Inc (BLUE) stock worth over $39,970. Details can be seen in Baird William D Iii's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Baird William D Iii has not made any transactions after 2024-01-05 and currently still holds the listed stock(s).

Transaction Summary of Baird William D Iii

To

Baird William D Iii Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Baird William D Iii owns 4 companies in total, including Axcella Health Inc (AXLA) , bluebird bio Inc (BLUE) , and Amicus Therapeutics Inc (FOLD) among others .

Click here to see the complete history of Baird William D Iii’s form 4 insider trades.

Insider Ownership Summary of Baird William D Iii

Ticker Comapny Transaction Date Type of Owner
AXLA Axcella Health Inc 2019-05-08 director
BLUE bluebird bio Inc 2021-02-17 Chief Financial Officer
FOLD Amicus Therapeutics Inc 2018-10-15 Chief Financial Officer
2024-01-05 Chief Financial Officer

Baird William D Iii Latest Holdings Summary

Baird William D Iii currently owns a total of 3 stocks. Among these stocks, Baird William D Iii owns 252,335 shares of 2seventy bio Inc (TSVT) as of January 5, 2024, with a value of $1 Million and a weighting of 49.24%. Baird William D Iii owns 117,622 shares of Amicus Therapeutics Inc (FOLD) as of October 15, 2018, with a value of $1 Million and a weighting of 49.01%. Baird William D Iii also owns 35,529 shares of bluebird bio Inc (BLUE) as of February 17, 2021, with a value of $39,970 and a weighting of 1.76%.

Latest Holdings of Baird William D Iii

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSVT 2seventy bio Inc 2024-01-05 252,335 4.44 1,119,106
FOLD Amicus Therapeutics Inc 2018-10-15 117,622 9.47 1,113,880
BLUE bluebird bio Inc 2021-02-17 35,529 1.13 39,970

Holding Weightings of Baird William D Iii


Baird William D Iii Form 4 Trading Tracker

According to the SEC Form 4 filings, Baird William D Iii has made a total of 10 transactions in 2seventy bio Inc (TSVT) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in 2seventy bio Inc is the sale of 1,380 shares on January 5, 2024, which brought Baird William D Iii around $5,175.

According to the SEC Form 4 filings, Baird William D Iii has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 10,000 shares on October 15, 2018, which brought Baird William D Iii around $122,300.

According to the SEC Form 4 filings, Baird William D Iii has made a total of 4 transactions in bluebird bio Inc (BLUE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in bluebird bio Inc is the sale of 693 shares on February 17, 2021, which brought Baird William D Iii around $19,515.

Insider Trading History of Baird William D Iii

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Baird William D Iii Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Baird William D Iii Ownership Network

Ownership Network List of Baird William D Iii

No Data

Ownership Network Relation of Baird William D Iii


Baird William D Iii Owned Company Details

What does Axcella Health Inc do?

Who are the key executives at Axcella Health Inc?

Baird William D Iii is the director of Axcella Health Inc. Other key executives at Axcella Health Inc include Senior Vice President & CIPO Paul Fehlner , director & President and CEO William Hinshaw , and 10 percent owner L.p. Fpa, .

Axcella Health Inc (AXLA) Insider Trades Summary

Over the past 18 months, Baird William D Iii made no insider transaction in Axcella Health Inc (AXLA). Other recent insider transactions involving Axcella Health Inc (AXLA) include a net sale of 5,221 shares made by Paul Fehlner ,

In summary, during the past 3 months, insiders sold 0 shares of Axcella Health Inc (AXLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 209 shares of Axcella Health Inc (AXLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 209 shares.

Axcella Health Inc (AXLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Axcella Health Inc Insider Transactions

No Available Data

Baird William D Iii Mailing Address

Above is the net worth, insider trading, and ownership report for Baird William D Iii. You might contact Baird William D Iii via mailing address: C/o Bluebird Bio, Inc., 60 Binney Street, Cambridge Ma 02142.

Discussions on Baird William D Iii

No discussions yet.